HFMA October 3, 2022
Lola Butcher

Healthcare researchers believe Medicare could save $2 billion by using a cheaper drug for retinal disease, but some physicians don’t want to switch.

Population health experts at CommonSpirit Health have singled out a costly drug with a much cheaper alternative that is not being prescribed by many physicians who could.

If just a portion of those non-prescribing physicians switched to the lower-cost retinal disease drug, researchers at Chicago-based CommonSpirit estimate that it would generate yearly savings for Medicare of $2.3 billion, an amount that exceeds the annual savings from the entire Medicare Shared Savings Program (MSSP).

The situation underscores some major flaws both with CMS’s payment model for the drugs involved and with the structure of Medicare...

Today's Sponsors

LEK
Teladoc Health
Amwell

Today's Sponsors

LEK
Teladoc Health

Today's Sponsor

Oliver Wyman

 
Topics: ACO (Accountable Care), CMS, Govt Agencies, Health System / Hospital, Healthcare System, Insurance, Medicare, Payment Models, Pricing / Spending, Provider, Value Based
Magellan Healthcare, Kyo Partner to Develop Outcome Standards for ABA Value-Based Care
How Acadia Healthcare Plans to Double Revenue by 2028
Healthcare executives also experiencing burnout: survey
Tips for being an effective healthcare IT leader, in 2023 and beyond
Will Healthcare Be Able to Handle the Silver Tsunami in 2030?